Skip to main content
Top
Published in: Heart and Vessels 3/2017

01-03-2017 | Original Article

Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting

Authors: Thomas Nyström, Martin J. Holzmann, Björn Eliasson, Ann-Marie Svensson, Jeanette Kuhl, Ulrik Sartipy

Published in: Heart and Vessels | Issue 3/2017

Login to get access

Abstract

We performed a nationwide population-based cohort study to investigate the association between estimated glucose disposal rate (eGDR) and long-term survival after coronary artery bypass grafting (CABG) in patients with type 2 diabetes. All patients who underwent primary CABG in Sweden from 2006 to 2013 were identified from the SWEDEHEART register and by record linkage to the National Diabetes Register; all patients with type 2 diabetes were included and formed the study population. Patients were followed until 2013 through national registers for major adverse cardiovascular events and death from any cause. eGDR was calculated using waist circumference, hemoglobin A1c, and presence or the absence of hypertension. The association between eGDR and death was estimated using multivariable Cox regression. A total of 3256 patients were included. During a mean follow-up of 3.1 years (10,227 person-years), in total, 14 % patients died: 17 % (n = 186) in the 1st tertile (lowest eGDR), 14 % (n = 145) in the 2nd tertile, and 13 % (n = 133) in the 3rd tertile (highest eGDR). There was a significant association between eGDR and increased risk of death: adjusted hazard ratio (95 % confidence interval): 1.46 (1.12–1.90) for the 1st eGDR tertile compared to the 3rd and highest eGDR tertile. In conclusion, patients with type 2 diabetes who underwent CABG, a low eGDR, were associated with an increased risk of long-term all-cause mortality that was independent of other cardiovascular and metabolic risk factors. Insulin resistance measured by eGDR could be a useful risk marker in patients with type 2 diabetes and ischemic heart disease.
Literature
1.
go back to reference Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14CrossRefPubMed Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14CrossRefPubMed
2.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321CrossRefPubMed
3.
go back to reference Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 21:1138–1145CrossRefPubMed Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 21:1138–1145CrossRefPubMed
4.
go back to reference Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W (2007) Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 167:1145–1151CrossRefPubMed Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W (2007) Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 167:1145–1151CrossRefPubMed
5.
go back to reference Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed
6.
go back to reference Laakso M, Kuusisto J (2014) Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 10:293–302CrossRefPubMed Laakso M, Kuusisto J (2014) Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 10:293–302CrossRefPubMed
7.
go back to reference Mohammadi S, Dagenais F, Mathieu P, Kingma JG, Doyle D, Lopez S, Baillot R, Perron J, Charbonneau E, Dumont E, Metras J, Desaulniers D, Voisine P (2007) Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 116:I220–225PubMed Mohammadi S, Dagenais F, Mathieu P, Kingma JG, Doyle D, Lopez S, Baillot R, Perron J, Charbonneau E, Dumont E, Metras J, Desaulniers D, Voisine P (2007) Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 116:I220–225PubMed
8.
go back to reference Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC, O’Connor GT, Ross CS, Northern New England Cardiovascular Disease Study Group (2004) Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110:41–44CrossRef Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC, O’Connor GT, Ross CS, Northern New England Cardiovascular Disease Study Group (2004) Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110:41–44CrossRef
9.
go back to reference Gallagher S, Kapur A, Lovell MJ, Jones DA, Kirkwood A, Hassan S, Archbold RA, Wragg A, Uppal R, Yaqoob MM (2014) Impact of diabetes mellitus and renal insufficiency on 5-year mortality following coronary artery bypass graft surgery: a cohort study of 4869 UK patients. Eur J Cardiothorac Surg 45:1075–1081CrossRefPubMed Gallagher S, Kapur A, Lovell MJ, Jones DA, Kirkwood A, Hassan S, Archbold RA, Wragg A, Uppal R, Yaqoob MM (2014) Impact of diabetes mellitus and renal insufficiency on 5-year mortality following coronary artery bypass graft surgery: a cohort study of 4869 UK patients. Eur J Cardiothorac Surg 45:1075–1081CrossRefPubMed
10.
go back to reference Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, Iaco AL, Canosa C, D’Alessandro S (2003) Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125:144–154CrossRefPubMed Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, Iaco AL, Canosa C, D’Alessandro S (2003) Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125:144–154CrossRefPubMed
11.
go back to reference Lazzeri C, Valente S, Chiostri M, Attanà P, Mattesini A, Nesti M, Gensini GF (2014) Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis. Heart Vessels 29:769–775CrossRefPubMed Lazzeri C, Valente S, Chiostri M, Attanà P, Mattesini A, Nesti M, Gensini GF (2014) Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis. Heart Vessels 29:769–775CrossRefPubMed
12.
go back to reference Bambace C, Sepe A, Zoico E, Telesca M, Olioso D, Venturi S, Rossi A, Corzato F, Faccioli S, Cominacini L, Santini F, Zamboni M (2014) Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes. Heart Vessels 29:42–48CrossRefPubMed Bambace C, Sepe A, Zoico E, Telesca M, Olioso D, Venturi S, Rossi A, Corzato F, Faccioli S, Cominacini L, Santini F, Zamboni M (2014) Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes. Heart Vessels 29:42–48CrossRefPubMed
13.
go back to reference Nakamura A, Monma Y, Kajitani S, Noda K, Nakajima S, Endo H, Takahashi T, Nozaki E (2015) Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease. Heart Vessels. doi:10.1007/s00380-015-0757-y Nakamura A, Monma Y, Kajitani S, Noda K, Nakajima S, Endo H, Takahashi T, Nozaki E (2015) Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease. Heart Vessels. doi:10.​1007/​s00380-015-0757-y
14.
go back to reference Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, Guyton RA, Thourani VH (2008) Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136:631–640CrossRefPubMed Halkos ME, Puskas JD, Lattouf OM, Kilgo P, Kerendi F, Song HK, Guyton RA, Thourani VH (2008) Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136:631–640CrossRefPubMed
15.
go back to reference Echahidi N, Pibarot P, Despres JP, Daigle JM, Mohty D, Voisine P, Baillot R, Mathieu P (2007) Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50:843–851CrossRefPubMed Echahidi N, Pibarot P, Despres JP, Daigle JM, Mohty D, Voisine P, Baillot R, Mathieu P (2007) Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50:843–851CrossRefPubMed
16.
go back to reference Angeloni E, Melina G, Benedetto U, Refice S, Capuano F, Roscitano A, Comito C, Sinatra R (2012) Metabolic syndrome affects midterm outcome after coronary artery bypass grafting. Ann Thorac Surg 93:537–544CrossRefPubMed Angeloni E, Melina G, Benedetto U, Refice S, Capuano F, Roscitano A, Comito C, Sinatra R (2012) Metabolic syndrome affects midterm outcome after coronary artery bypass grafting. Ann Thorac Surg 93:537–544CrossRefPubMed
17.
go back to reference Kasai T, Miyauchi K, Kajimoto K, Kubota N, Yanagisawa N, Amano A, Daida H (2009) Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period. Atherosclerosis 207:195–199CrossRefPubMed Kasai T, Miyauchi K, Kajimoto K, Kubota N, Yanagisawa N, Amano A, Daida H (2009) Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period. Atherosclerosis 207:195–199CrossRefPubMed
18.
go back to reference Kajimoto K, Kasai T, Miyauchi K, Hirose H, Yanagisawa N, Yamamoto T, Takazawa K, Niinami H, Hosoda Y, Daida H, Amano A (2008) Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 72:1481–1486CrossRefPubMed Kajimoto K, Kasai T, Miyauchi K, Hirose H, Yanagisawa N, Yamamoto T, Takazawa K, Niinami H, Hosoda Y, Daida H, Amano A (2008) Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 72:1481–1486CrossRefPubMed
19.
go back to reference Hallberg V, Palomaki A, Lahtela J, Voutilainen S, Tarkka M, Kataja M, Study G (2014) Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG. Cardiovasc Diabetol 13:25CrossRefPubMedPubMedCentral Hallberg V, Palomaki A, Lahtela J, Voutilainen S, Tarkka M, Kataja M, Study G (2014) Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG. Cardiovasc Diabetol 13:25CrossRefPubMedPubMedCentral
20.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
21.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed
22.
go back to reference Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ (2000) Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626–632CrossRefPubMed Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ (2000) Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626–632CrossRefPubMed
23.
go back to reference Kilpatrick ES, Rigby AS, Atkin SL (2007) Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 30:707–712CrossRefPubMed Kilpatrick ES, Rigby AS, Atkin SL (2007) Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 30:707–712CrossRefPubMed
24.
go back to reference Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L (2010) The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Heart 96:1617–1621CrossRefPubMed Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L (2010) The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Heart 96:1617–1621CrossRefPubMed
25.
go back to reference Harnek J, Nilsson J, Friberg Ö, James S, Lagerqvist B, Hambraeus K, Cider A, Svennberg L, Attebring MF, Held C, Johansson P, Jernberg T (2013) The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART). Scand Cardiovasc J 47(Suppl 62):1–10CrossRefPubMed Harnek J, Nilsson J, Friberg Ö, James S, Lagerqvist B, Hambraeus K, Cider A, Svennberg L, Attebring MF, Held C, Johansson P, Jernberg T (2013) The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART). Scand Cardiovasc J 47(Suppl 62):1–10CrossRefPubMed
26.
go back to reference Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF (2015) Review of 103 Swedish healthcare quality registries. J Intern Med 277:94–136CrossRefPubMed Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF (2015) Review of 103 Swedish healthcare quality registries. J Intern Med 277:94–136CrossRefPubMed
27.
go back to reference Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjornsdottir S (2012) The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55:2946–2953CrossRefPubMed Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjornsdottir S (2012) The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55:2946–2953CrossRefPubMed
28.
go back to reference Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24:659–667CrossRefPubMedPubMedCentral Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24:659–667CrossRefPubMedPubMedCentral
29.
go back to reference Holzmann MJ, Rathsman B, Eliasson B, Kuhl J, Svensson AM, Nyström T, Sartipy U (2015) Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. J Am Coll Cardiol 65:1644–1652CrossRefPubMed Holzmann MJ, Rathsman B, Eliasson B, Kuhl J, Svensson AM, Nyström T, Sartipy U (2015) Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. J Am Coll Cardiol 65:1644–1652CrossRefPubMed
30.
go back to reference Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450CrossRefPubMedPubMedCentral Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450CrossRefPubMedPubMedCentral
31.
go back to reference Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP (2013) Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care 36:2280–2285CrossRefPubMedPubMedCentral Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP (2013) Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care 36:2280–2285CrossRefPubMedPubMedCentral
32.
go back to reference Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM, IFCC Working Group on HbA1c Standardization (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM, IFCC Working Group on HbA1c Standardization (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed
33.
go back to reference Lind M, Odén A, Fahlén M, Eliasson B (2008) A systematic review of glycated hemoglobin variables used in the study of diabetic complications. Diab Met Syndr Clin Res Rev 2:282–293 Lind M, Odén A, Fahlén M, Eliasson B (2008) A systematic review of glycated hemoglobin variables used in the study of diabetic complications. Diab Met Syndr Clin Res Rev 2:282–293
34.
go back to reference Ingelsson E, Arnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787–791CrossRefPubMed Ingelsson E, Arnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787–791CrossRefPubMed
35.
go back to reference White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30:377–399CrossRefPubMed White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30:377–399CrossRefPubMed
37.
go back to reference Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R (2009) Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 32:361–366CrossRefPubMedPubMedCentral Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R (2009) Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 32:361–366CrossRefPubMedPubMedCentral
38.
go back to reference Engel AM, McDonough S, Smith JM (2009) Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 88:1793–1800CrossRefPubMed Engel AM, McDonough S, Smith JM (2009) Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 88:1793–1800CrossRefPubMed
39.
go back to reference van Straten AH, Bramer S, Soliman Hamad MA, van Zundert AA, Martens EJ, Schonberger JP, de Wolf AM (2010) Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg 89:30–37CrossRefPubMed van Straten AH, Bramer S, Soliman Hamad MA, van Zundert AA, Martens EJ, Schonberger JP, de Wolf AM (2010) Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg 89:30–37CrossRefPubMed
40.
go back to reference Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823CrossRefPubMed Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823CrossRefPubMed
41.
go back to reference Angeloni E, Paneni F, Landmesser U, Benedetto U, Melina G, Luscher TF, Volpe M, Sinatra R, Cosentino F (2013) Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J 34:3557–3562CrossRefPubMed Angeloni E, Paneni F, Landmesser U, Benedetto U, Melina G, Luscher TF, Volpe M, Sinatra R, Cosentino F (2013) Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J 34:3557–3562CrossRefPubMed
42.
go back to reference Tennyson C, Lee R, Attia R (2013) Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery? Interact CardioVasc Thorac Surg 17:1000–1008CrossRefPubMedPubMedCentral Tennyson C, Lee R, Attia R (2013) Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery? Interact CardioVasc Thorac Surg 17:1000–1008CrossRefPubMedPubMedCentral
43.
go back to reference Hudson CC, Welsby IJ, Phillips-Bute B, Mathew JP, Lutz A, Chad Hughes G, Stafford-Smith M, Cardiothoracic Anesthesiology Research Endeavors G (2010) Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth 57:565–572CrossRefPubMed Hudson CC, Welsby IJ, Phillips-Bute B, Mathew JP, Lutz A, Chad Hughes G, Stafford-Smith M, Cardiothoracic Anesthesiology Research Endeavors G (2010) Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth 57:565–572CrossRefPubMed
44.
go back to reference McGinn JT Jr, Shariff MA, Bhat TM, Azab B, Molloy WJ, Quattrocchi E, Farid M, Eichorn AM, Dlugacz YD, Silverman RA (2011) Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic history. J Cardiothorac Surg 6:104CrossRefPubMedPubMedCentral McGinn JT Jr, Shariff MA, Bhat TM, Azab B, Molloy WJ, Quattrocchi E, Farid M, Eichorn AM, Dlugacz YD, Silverman RA (2011) Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic history. J Cardiothorac Surg 6:104CrossRefPubMedPubMedCentral
45.
go back to reference Matsuura K, Imamaki M, Ishida A, Shimura H, Niitsuma Y, Miyazaki M (2009) Off-pump coronary artery bypass grafting for poorly controlled diabetic patients. Ann Thorac Cardiovasc Surg 15:18–22PubMed Matsuura K, Imamaki M, Ishida A, Shimura H, Niitsuma Y, Miyazaki M (2009) Off-pump coronary artery bypass grafting for poorly controlled diabetic patients. Ann Thorac Cardiovasc Surg 15:18–22PubMed
46.
go back to reference Knapik P, Ciesla D, Filipiak K, Knapik M, Zembala M (2011) Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg 39:484–489CrossRefPubMed Knapik P, Ciesla D, Filipiak K, Knapik M, Zembala M (2011) Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg 39:484–489CrossRefPubMed
47.
go back to reference Tsuruta R, Miyauchi K, Yamamoto T, Dohi S, Tambara K, Dohi T, Inaba H, Kuwaki K, Daida H, Amano A (2011) Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 57:181–186CrossRefPubMed Tsuruta R, Miyauchi K, Yamamoto T, Dohi S, Tambara K, Dohi T, Inaba H, Kuwaki K, Daida H, Amano A (2011) Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 57:181–186CrossRefPubMed
48.
go back to reference Sharma PK, Agarwal S, Ellis SG, Goel SS, Cho L, Tuzcu EM, Lincoff AM, Kapadia SR (2014) Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 7:503–509CrossRefPubMed Sharma PK, Agarwal S, Ellis SG, Goel SS, Cho L, Tuzcu EM, Lincoff AM, Kapadia SR (2014) Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 7:503–509CrossRefPubMed
49.
50.
go back to reference Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591CrossRefPubMed Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591CrossRefPubMed
Metadata
Title
Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting
Authors
Thomas Nyström
Martin J. Holzmann
Björn Eliasson
Ann-Marie Svensson
Jeanette Kuhl
Ulrik Sartipy
Publication date
01-03-2017
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 3/2017
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-016-0875-1

Other articles of this Issue 3/2017

Heart and Vessels 3/2017 Go to the issue